Abstract
Stomach cancer and endometriosis of the uterus is one of the most common diseases, occupying a significant place in the structure of morbidity and mortality (V.I. Chissov, V.V. Starinskiy, 2002; V.M. Merabishvili, 2011). Up to 800,000 people die from stomach cancer in the world every year. Among the oncological morbidity of the population of the Russian Federation, stomach cancer takes the 2nd place, second only to tumors of the lung, trachea and bronchi (V.I. Chissov; V.V. Starinskiy; B.N.Kovalev; JI.B. Remennik, 2006). According to the Ministry of Health of the Republic of Uzbekistan, in terms of frequency of occurrence, stomach cancer is in second place after breast cancer. Unfortunately, in more than 50% of cases, the primary detection of endometriosis of the uterus in these patients occurs in advanced stages, when their treatment is rather difficult and in most cases is palliative in nature, aimed at some increase in life expectancy and improvement of its quality. (2018 year)